FDG positron emission tomography in diffuse Lewy body disease: A case report

Clinical Nuclear Medicine

Volumn 25, Issue 12, 2000, Pages 1004-1006

  Tatlidil, Rozet ^a,b   New, Pamela ^a   Mayberg, Helen ^a  

^a UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^b NONE   (Turkey)

Author keywords

Dementia; Fluorodeoxyglucose; Lewy Body Disease; Parkinsonism; Positron Emission Tomography

Indexed keywords

FLUORODEOXYGLUCOSE;

ADULT; ARTICLE; CASE REPORT; COGNITIVE DEFECT; DEMENTIA; DIFFUSE LEWY BODY DISEASE; FEMALE; HISTOPATHOLOGY; HUMAN; MOTOR DYSFUNCTION; PARKINSON DISEASE; PARKINSONISM; POSITRON EMISSION TOMOGRAPHY; VISUAL HALLUCINATION;

BRAIN; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LEWY BODY DISEASE; MIDDLE AGED; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033659891     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-200012000-00009     Document Type: Article

References (16)

1. Evaluation of the predictive validity inter-rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type
2. Report of the Second Dementia with Lewy Body International Workshop: Diagnosis and treatment. Consortium on Dementia with Lewy Bodies
3. Dimished neuronal metabolic activity in Alzheimer's disease
4. Can neuroimaging techniques identify individuals at risk of developing Alzheimer's disease? Int Psychogeriatr
5. Clinical studies of cerebral blood flow in Alzheimer's disease
6. Clinical and neuroimaging features of familial Alzheimer's disease
7. FDG PET and differential diagnosis of dementia
8. Positron emission tomography for diagnosis of Alzheimer's disease and vascular dementia
9. 18F] fluorodeoxyglucose
10. Fluorodeoxyglucose positron emission tomography in diffuse Lewy body disease
11. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease: A comparative study using positron emission tomography
12. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease
13. The metabolic topography of Parkinsonism
14. D1/D2 actions of dopaminergic drugs studied with [14C]-2-deoxyglucose autoradiography
15. Parkinson rigidity, dopa-induced dyskinesia and chorea: Dynamic studies on the basal ganglia-thalamocortical motor circuit using PET scan and depth microrecording
16. Asymmetry of basal ganglia glucose metabolism and dopa responsiveness in parkinsonism